RESEARCH TRIANGLE PARK, N.C., Jan. 6, 2018 /PRNewswire/ -- iNNO Clinical today announced it is changing its name to Aperio
Aperio Clinical Outcomes provides both comprehensive and customizable clinical research services across multiple therapeutic areas. In addition, Aperio offers consulting services in quality assurance, strategic resourcing, and practical application of the latest technologies being implemented in clinical trials.
Faye Woolf, founder and CEO of Aperio, is an industry expert with over 25 years of experience in clinical trials. Faye's commitment is clear: "At Aperio, we'll tell you plainly what we're going to do: build the right team, establish strong relationships with sites and clients, and devote ourselves to honest interaction every step of the way. And then we'll do it, always keeping the human element at the forefront. That's how we deliver the results our clients deserve."
Woolf says that she created Aperio in response to what she has seen in the clinical trials sector. "Experience has taught us that being open and honest, following through on what we say, and valuing and supporting people at every step creates successful and lasting relationships — I've worked with some of the same people for more than 20 years. So our business was built on those principles, and they guide the work we do every day."
The name Aperio comes from the Latin word for "uncover" or "reveal." That focus on transparency in clinical trials begins with being clear upfront about what projects are a fit for Aperio's capabilities, and extends through every step in the clinical trial process. "We'll tell you the truth—no matter what," says Woolf. "We won't hide uncomfortable facts. We won't use smoke and mirrors to distort reality. If Aperio can't do an excellent job for you, we won't take the work."
About Aperio Clinical Outcomes
Aperio Clinical Outcomes provides full, customizable clinical research services across multiple therapeutic areas. Dedicated to transparent interactions with clients, Aperio also offers consulting services in Quality Assurance, Strategic Resourcing, and practical application of the latest Clinical Trial Technology.
In an industry flooded with data, metrics and technology, Aperio remains steadfastly focused on the most important part of the process: people. From start-up to close out and every point in between, Aperio works with its partners to deliver outcomes that will improve patient care and save lives.
Aperio Clinical Outcomes.We make it clear.
Erica GreenAperio Clinical Outcomes Research Triangle Park, NC 919-636-4074
View original content:http://www.prnewswire.com/news-releases/inno-clinical-announces-name-change-to-aperio-clinical-outcomes-300593808.html
SOURCE Aperio Clinical Outcomes
Subscribe to our Free Newsletters!
Blount's disease is a developmental disorder in which the shinbone is affected, resulting in ...
Acanthosis nigricans is a skin condition in which discoloration and hyperpigmentation of the skin ...
Gastrointestinal Bleeding refers to hemorrhage that occurs from one or more portions of the ...View All